Storia in 7 fonti

Why these 8 stocks including Pharma majors will remain in focus on today following Trump’s tariff announcement

Maruti Suzuki’s price hike, Anant Raj demerger, Aurobindo Pharma getting nod for bio similar, Anupam Rasayn open offer to Bliss GVS shareholders

Raccontata da

timesofindia.indiatimes.com

economictimes.indiatimes.com

thehindubusinessline.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo1 mese fa

Why these 8 stocks including Pharma majors will remain in focus on today following Trump’s tariff announcement

Maruti Suzuki’s price hike, Anant Raj demerger, Aurobindo Pharma getting nod for bio similar, Anupam Rasayn open offer to Bliss GVS shareholders

originale

Timeline cronologica

mercoledì 22 luglio 2026·timesofindia.indiatimes.com
Trump announces 0% tariff on generic medicines for two years; 200% thereafter
US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years…
mercoledì 22 luglio 2026·economictimes.indiatimes.com
Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

Trump ⁠has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.

Why these 8 stocks including Pharma majors will remain in focus on today following Trump’s tariff announcement

Confronto fonti

Why these 8 stocks including Pharma majors will remain in focus on today following Trump’s tariff announcement

Timeline cronologica

Trump announces 0% tariff on generic medicines for two years; 200% thereafter

Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla…

Stocks fall, pharma firms fret. Indian drug manufacturers sweat over Trump's 100% levy on generics

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners

US to impose 100% tariffs on generic medicine imports from Aug 2028

Trump announces 100% tariffs on imported generic pharmaceutical drugs

Why these 8 stocks including Pharma majors will remain in focus on today following Trump’s tariff announcement

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

0%, 100%, then 200%: How Trump's new generic drug tariff plan could hit India

Trump threatens tariff on generic medicines: Should India be worried?

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

Trump’s proposed generic drug tariffs ‘not practical’, says Indian pharma; US consumers will pay the price

0% now, 100% in 2 years, 200% by 2029—US plan for generic pharma tariffs & what it means for India

Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3%

Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm

Pharma stocks decline; Aurobindo Pharma down over 4%

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

Trump’s 100% generic drug duty threatens US low-cost supply

200% Trump tariff shock? India’s cheap pills may still beat US rivals

Indian pharma firms may yet survive Trump's 200% tariff bombshell

Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors